Congenital Anomalies Treatment Market Outlook:
Congenital Anomalies Treatment Market size is valued at USD 179.5 million in 2025 and is projected to reach USD 283.2 million by the end of 2035, rising at a CAGR of 5.2% during the forecast period, i.e., 2026‑2035. In 2026, the industry size of congenital anomalies treatment is estimated at USD 188.8 million.
The global patient pool for the congenital anomalies treatment market is growing due to birth rates in relatively lower-income countries increasing and diagnostic facilities improving in higher-income settings. According to a report by the World Health Organization in February 2023, on average, around 240,000 newborns die within a span of 28 days due to congenital disorders, with more than 170,000 deaths occurring between 1 month and 5 years of age. This very burden has caused demand for interventions to experience upward pressure during the very early stages, particularly in prenatal screening and corrective treatments. Supply chains remain dependent on very high-precision imports of APIs, diagnostic reagents, and implantable devices, especially in developing markets.
Key components of the supply chains supporting the market consist of active pharmaceutical ingredients (API) for prenatal and postnatal diagnostics, surgical devices for corrective interventions, and specialized nutritional/therapeutic products. Furthermore, emerging trends offer proxy awareness about the producer price index (PPI) and consumer price index (CPI) as tracked by the U.S. Bureau of Labor Statistics (BLS). As per a report by the U.S. Bureau of Labor Statistics (BLS) in September 2025, in May 2025, the producer price index for surgical and medical instruments was at 157.8. The upward trend directly determines the structure of costs for the market and the downstream pricing strategies and investment decisions.
PPI Commodity Indexes in Healthcare and Their Relative Importance as of December 2022
|
Index title |
Relative Importance in Final Demand, December 2022 (%) |
Relative Importance in Health Care Services, December 2022 (%) |
|
Health care services |
16.6 |
100.0 |
|
Outpatient care |
10.6 |
63.6 |
|
Physician care |
4.0 |
23.7 |
|
Medical laboratory and diagnostic imaging center care |
0.3 |
2.4 |
|
Home health and hospice care |
0.9 |
5.3 |
|
Hospital outpatient care |
4.3 |
25.4 |
|
Dental Care |
1.1 |
6.7 |
|
Inpatient Care |
6.0 |
35.8 |
|
Hospital inpatient care |
4.5 |
26.9 |
|
Nursing home care |
1.2 |
7.3 |
|
Intellectual and developmental disability center care |
0.3 |
1.5 |
|
Sales of blood and blood products, organs, and tissues |
0.1 |
0.6 |
Source: U.S. BLS
